NVCR

NovoCure Limited Ordinary Shares#30 · 2019BreakoutB

Yearly return

+158%

Peak return

+202%

Max drawdown

-31%

ADR (20 days)

+3.5%

Base

10 days / -22.5%

Prior run

+43%

Breakout volume

3.0x

Pivot

$37.21

Earnings, Guidance oder Umsatz-/EPS-Revision als Neubewertungsanker. Beleg: offizielles 8-K-Filing bei der SEC.

Healthcare · Healthcare & Biotech

Continue in the full Atlas

Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare NVCR with the current market directly.